CWIAX
Price
$82.59
Change
+$0.54 (+0.66%)
Updated
Jun 2 closing price
Net Assets
151.89B
MGQAX
Price
$12.75
Change
-$0.03 (-0.23%)
Updated
Jun 2 closing price
Net Assets
22.73M
Interact to see
Advertisement

CWIAX vs MGQAX

Header iconCWIAX vs MGQAX Comparison
Open Charts CWIAX vs MGQAXBanner chart's image
CWIAX vs MGQAX Comparison Chart in %
View a ticker or compare two or three
VS
CWIAX vs. MGQAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIAX is a Buy and MGQAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIAX has more cash in the bank: 152B vs. MGQAX (22.7M). CWIAX pays higher dividends than MGQAX: CWIAX (1.33) vs MGQAX (0.00). CWIAX was incepted earlier than MGQAX: CWIAX (24 years) vs MGQAX (13 years). MGQAX (1.88) is less costly to investors than CWIAX (0.75). MGQAX is a more actively managed with annual turnover of: 49.00 vs. CWIAX (44.00). MGQAX initial investment is less costly to investors than CWIAX (4%) vs CWIAX (4%). CWIAX has a lower initial minimum investment than MGQAX: CWIAX (250) vs MGQAX (1000). CWIAX annual gain was more profitable for investors over the last year : 22.44 vs. MGQAX (-28.16). CWIAX return over 5 years is better than : 38.19 vs. MGQAX (-26.65).
CWIAXMGQAXCWIAX / MGQAX
Total Expense Ratio0.751.1565%
Annual Report Gross Expense Ratio0.751.8840%
Fund Existence24 years13 years-
Gain YTD15.652-2.368-661%
Front Load4%5%67%
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets152B22.7M669,604%
Annual Yield % from dividends1.330.00-
Returns for 1 year22.44-28.16-80%
Returns for 3 years54.65-23.63-231%
Returns for 5 years38.19-26.65-143%
Returns for 10 years122.637.971,538%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSHAX12.600.20
+1.61%
NYLI Cushing® MLP Premier Class A
JCPRX25.76N/A
N/A
JPMorgan US Large Cap Core Plus R5
OIEIX26.19N/A
N/A
JPMorgan Equity Income A
RYBOX65.18N/A
N/A
Rydex Biotechnology A
PSKCX23.33N/A
N/A
Virtus KAR Mid-Cap Growth C